2.
ES-SCLC患者局部治疗各组间临床特征比较
Clinical characteristics of ES-SCLC patients between local treatment groups
| Clinical characteristics | n | Primary tumor radiotherapy plus chemotherapy/Chemotherapy | None/Single-site/Mutiple-site local treatment | None/Passive/Initiative treatment | PCI/No PCI |
| *: P < 0.05. | |||||
| Total | 275 | 122/153 | 166/85/24 | 166/43/66 | 34/241 |
| Gender | 29/183 | ||||
| Male | 212 | 90/122 | 131/62/19 | 131/28/53 | 5/58 |
| Female | 63 | 32/31 | 35/23/5 | 35/15/13 | |
| Age (yr) | 23/153 | ||||
| < 65 | 176 | 72/104* | 107/53/16 | 107/24/45 | 11/88 |
| ≥65 | 99 | 50/49 | 59/32/8 | 59/19/21 | |
| ECOG | 33/204 | ||||
| 0-1 | 237 | 108/129 | 143/75/19 | 143/34/60 | 1/37 |
| 2-3 | 38 | 14/24 | 23/10/5 | 23/9/6 | |
| Brain metastases | —— | ||||
| Yes | 60 | 27/33 | 19/29/12* | 19/18/23* | —— |
| No | 215 | 95/120 | 147/56/12 | 147/25/43 | |
| Chemotherapy scheme | 31/188 | ||||
| EP or EC | 219 | 97/122 | 134/71/14 | 134/35/50 | 3/53 |
| Not EP or EC | 56 | 25/31 | 32/14/10 | 32/8/16 | |